摘要
将高致病力禽流感病毒分离株A/Goose/Guangdong/1/96(HSN1)(GD/1/96)的HA基因cDNA片段克隆于强启动子CMV下游,构建了 DNA疫苗质粒 pCIH5,对其免疫保护性进行了三批不同层次的动物保护试验。试验I分为两部分,第一部分为pCIH5一次免疫组(10μg、40μg、70μg、100μg、150μg)、油苗组及空白对照组,第二部分为 pCIH5两次免疫组(5μg、20μg、35μg、50μg)及其对照组,pCIH5以200μl腿肌两点注射,一次免疫组于免疫后3周以10LD50CD/1/96攻毒,两次免疫组首免后3周加强免疫一次,二免后2周以50LD50CD/1/96攻毒,免疫及攻毒前后均采血检测HI抗体和AGP抗体,攻毒后7天采集泻殖腔棉拭子分离病毒。试验Ⅱ分为50μg和 100μg(100μl)两次免疫组及对照组,攻毒剂量为 10LD50CD/1/96。试验Ⅲ为试验Ⅱ的重复试验,但免疫注射体积为200μl。结果,三批试验的所有对照鸡在攻毒后 2- 8天全部死亡;试验Ⅰ中 10μg、40μg、70μg、100μg和 150μg pCIH5一次免疫,但免疫保护率分别为12.5%(1/8?
The HA cDNA from HPAIV A/Goose /Guangdong/1/96 (H5 N1 ) (CD/1/96) was cloned under a CMV promoter to generate vac- cine plasmid pCIH5 .The protective experiments in SPF chickens were separated into three portions. The experiment I include inactived oil-emulsion vaccine groups(vaccine once),groups(vaccine twice)and two control groups.The one- time -vaccine groups were challenged with 10 LD50 GD/1/96 3 weeks after vaccine.The two-time-vaccine groups were boosted 3 weeks after prim- ing and were ch...
出处
《中国预防兽医学报》
CAS
CSCD
2000年第S1期173-,共1页
Chinese Journal of Preventive Veterinary Medicine
关键词
禽流感病毒
血凝索基因
DNA疫苗
免疫保护
Avian influenza virus
Hemagglutinin gene
DNA vaccine
Immune protection